VIR 8-K: Secondary offering

Vir Biotechnology

Filed with the SEC on · accession 0001193125-26-461412

VIR filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -3.8% by the first close after the filing.

Summary of the filing

Vir Biotechnology entered into an underwriting agreement to sell 15,000,000 shares of common stock at $10.00 per share, expecting net proceeds of approximately $140.4 million, with an option for underwriters to purchase up to an additional 2,250,000 shares.

Key details

Public offering price per share$10
Number of shares offered$15.0M
Net proceeds from offering$140.4M
Net proceeds if over-allotment exercised in full$161.5M
Additional shares option$2.3M
IssuerVir Biotechnology, Inc.
UnderwriterLeerink Partners LLC
UnderwriterMorgan Stanley & Co. LLC
UnderwriterEvercore Group L.L.C.
Legal counselGunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
Chief executive officerMarianne De Backer

How VIR stock reacted

Close before

$9.96

Nov 13, 2026

First close after

-3.82%

$9.58

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for VIR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VIR?

Click here

Frequently asked questions

What did VIR file with the SEC on Nov 16, 2026?

VIR filed a 8-K (Secondary offering). Vir Biotechnology entered into an underwriting agreement to sell 15,000,000 shares of common stock at $10.00 per share, expecting net proceeds of approximately $140.4 million, with an option for underwriters to purchase up to an additional 2,250,000 shares.

What does a secondary offering mean for VIR stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did VIR stock react to this filing?

VIR closed at $9.96 before the filing and $9.58 on Nov 16, 2026 (-3.82%).

Other VIR SEC filings

Get alerts when VIR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days